Type:
|
Approved drug |
PubChem:
|
60838
|
DrugBank:
|
DB00762
|
IUPAC:
|
4-(1-piperidinyl)-1-piperidinecarboxylic acid [(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]heneicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] ester |
Standard InChI:
|
InChI=1S/C33H38N4O6/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3/t33-/m0/s1 |
Standard InChIKey:
|
UWKQSNNFCGGAFS-XIFFEERXSA-N |
SMILES:
|
CCC1=C2CN3C(=CC4=C(COC(=O)C4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(N4CCCCC4)CC3)C=C12 |
Metabolism-related information:
|
Metabolite may cause severe diarrhea
|
Reference:
|
10.1080/03602532.2020.1718691 |